Search Results

There are 1579 results for: content related to: Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: Results of a fifty-two–week, randomized, controlled study

  1. Pharmacokinetics of Etoricoxib in Patients with Hepatic Impairment

    The Journal of Clinical Pharmacology

    Volume 43, Issue 10, October 2003, Pages: 1136–1148, Dr. Nancy G. B. Agrawal, Dr. Mark J. Rose, Ms. Catherine Z. Matthews, Dr. Eric J. Woolf, Dr. Arturo G. Porras, Dr. Leslie A. Geer, Mr. Patrick J. Larson, Ms. Josee Cote, Ms. Stacy C. Dilzer, Dr. Kenneth C. Lasseter, Dr. Imtiaz Alam, Dr. Kevin J. Petty and Dr. Keith M. Gottesdiener

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003257219

  2. Pharmacokinetics of Etoricoxib in Patients with Renal Impairment

    The Journal of Clinical Pharmacology

    Volume 44, Issue 1, January 2004, Pages: 48–58, Dr Nancy G. B. Agrawal, Ms Catherine Z. Matthews, Mr Ralph S. Mazenko, Mr Walter F. Kline, Dr Eric J. Woolf, Dr Arturo G. Porras, Ms Leslie A. Geer, Ms Peggy H. Wong, Dr Meehung Cho, Ms Josee Cote, Dr Thomas C. Marbury, Dr Jack W. Moncrief, Dr Harry Alcorn Jr., Dr Suzanne Swan, Dr Marshall R. Sack, Dr Richard A. Robson, Dr Kevin J. Petty, Dr Jules I. Schwartz and Dr Keith M. Gottesdiener

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003260338

  3. Characterization of Etoricoxib, a Novel, Selective COX-2 Inhibitor

    The Journal of Clinical Pharmacology

    Volume 43, Issue 6, June 2003, Pages: 573–585, Ms Aimee Dallob, Dr Christopher J. Hawkey, Dr Howard Greenberg, Mr Nicholas Wight, Dr Paul De Schepper, Dr Scott Waldman, Ms Peggy Wong, Dr Lisa DeTora, Dr Barry Gertz, Dr Nancy Agrawal, Dr John Wagner and Dr Keith Gottesdiener

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003253703

  4. The Effects of Modifying In Vivo Cytochrome P450 3A (CYP3A) Activity on Etoricoxib Pharmacokinetics and of Etoricoxib Administration on CYP3A Activity

    The Journal of Clinical Pharmacology

    Volume 44, Issue 10, October 2004, Pages: 1125–1131, Dr Nancy G. B. Agrawal, Ms Catherine Z. Matthews, Mr Ralph S. Mazenko, Dr Eric J. Woolf, Dr Arturo G. Porras, Dr Xun Chen, Ms Jutta L. Miller, Ms Nicole Michiels, Dr Martin Wehling, Dr Armin Schultz, Dr Alice B. Gottlieb, Dr Walter K. Kraft, Dr Howard E. Greenberg, Dr Scott A. Waldman, Dr Sean P. Curtis and Dr Keith M. Gottesdiener

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004268129

  5. Simultaneous determination of unlabeled and carbon-13-labeled etoricoxib, a new cyclooxygenase-2 inhibitor, in human plasma using HPLC–MS/MS

    Journal of Pharmaceutical Sciences

    Volume 91, Issue 2, February 2002, Pages: 405–416, M. J. Rose, N. Agrawal, E. J. Woolf and B. K. Matuszewski

    Version of Record online : 14 JAN 2002, DOI: 10.1002/jps.10038

  6. Examination of the Effect of Increasing Doses of Etoricoxib on Oral Methotrexate Pharmacokinetics in Patients With Rheumatoid Arthritis

    The Journal of Clinical Pharmacology

    Volume 49, Issue 10, October 2009, Pages: 1202–1209, Dr Jules I. Schwartz, Dr Nancy G. B. Agrawal, Dr P. H. Wong, Ms Jutta Miller, Dr Kenneth Bachmann, Dr Thomas Marbury, Dr David Hoelscher, Dr Paul F. Cavanaugh Jr and Dr Keith Gottesdiener

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009338939

  7. The Effect of Etoricoxib on the Pharmacokinetics of Oral Contraceptives in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 49, Issue 7, July 2009, Pages: 807–815, Dr Jules Schwartz, Dr Thomas Hunt, Dr William B. Smith, Dr Peggy Wong, Mr Patrick Larson, Ms Tami Crumley, Mr Anish Mehta, Dr Keith Gottesdiener and Dr Nancy Agrawal

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009337131

  8. The Effect of Etoricoxib on the Pharmacodynamics and Pharmacokinetics of Warfarin

    The Journal of Clinical Pharmacology

    Volume 47, Issue 5, May 2007, Pages: 620–627, Dr Jules I. Schwartz, Dr Nancy G. B. Agrawal, Dr Alan H. Hartford, Mr Josee Cote, Dr Thomas L. Hunt, Dr Rene Verbesselt, Mr Dane R. Eckols and Dr Keith M. Gottesdiener

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007299758

  9. Single- and Multiple-Dose Pharmacokinetics of Etoricoxib, a Selective Inhibitor of Cyclooxygenase-2, in Man

    The Journal of Clinical Pharmacology

    Volume 43, Issue 3, March 2003, Pages: 268–276, Dr. Nancy G. B. Agrawal, Dr. Arturo G. Porras, Dr. Catherine Z. Matthews, Dr. Mark J. Rose, Dr. Eric J. Woolf, Dr. Bret J. Musser, Ms. Andrea L. Dynder, Ms. Katherine E. Mazina, Dr. Kenneth C. Lasseter, Dr. Thomas L. Hunt, Dr. Jules I. Schwartz, Dr. Jacqueline B. McCrea and Dr. Keith M. Gottesdiener

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003251122

  10. You have free access to this content
    Single dose oral etoricoxib for acute postoperative pain in adults

    Intervention Review

    The Cochrane Library

    Rachel Clarke, Sheena Derry and R Andrew Moore

    Published Online : 8 MAY 2014, DOI: 10.1002/14651858.CD004309.pub4

  11. Effects of Etoricoxib and Comparator Nonsteroidal Anti-Inflammatory Drugs on Urinary Sodium Excretion, Blood Pressure, and Other Renal Function Indicators in Elderly Subjects Consuming a Controlled Sodium Diet

    The Journal of Clinical Pharmacology

    Volume 47, Issue 12, December 2007, Pages: 1521–1531, Dr Jule I. Schwartz, Dr Chau Thach, Dr Kennet C. Lasseter, Dr Jutta Miller, Dr David Hreniuk, Dr Debora A. Hilliard, Dr Kare M. Snyder, Dr Barr J. Gertz and Dr Keit M. Gottesdiener

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007307878

  12. Lack of Effect of Antacids on Single-Dose Pharmacokinetics of Etoricoxib

    The Journal of Clinical Pharmacology

    Volume 47, Issue 10, October 2007, Pages: 1342–1346, Dr Jules I. Schwartz, Dr Nancy G. B. Agrawal, Ms Uma A. Kher, Dr Marina DeSmet, Dr Paul F. Cavanaugh Jr, Dr Michel Guillaume, Dr David L. Ebel, Dr Shelia A. Merschman and Dr John A. Wagner

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007304777

  13. You have free access to this content
    Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease

    Intervention Review

    The Cochrane Library

    Xin-Pu Miao, Jian-Sheng Li, Qin Ouyang, Ren-Wei Hu, Yan Zhang and Hui-Yan Li

    Published Online : 23 OCT 2014, DOI: 10.1002/14651858.CD007744.pub2

  14. Etoricoxib pre-medication for post-operative pain after laparoscopic cholecystectomy

    Acta Anaesthesiologica Scandinavica

    Volume 50, Issue 6, July 2006, Pages: 688–693, A. Puura, 1 P. Puolakka, 2 M. Rorarius, 2 R. Salmelin and 3 L. Lindgren 2

    Version of Record online : 26 JUN 2006, DOI: 10.1111/j.1399-6576.2006.01049.x

  15. Influence of etoricoxib on anticonvulsant activity of phenytoin and diazepam in experimental seizure models in mice

    Journal of Pharmacy and Pharmacology

    Volume 62, Issue 5, May 2010, Pages: 610–614, R. Jayaraman, K.T. Manisenthil, T. Anitha, Vishal D. Joshi, Narahari N. Palei, Kalpesh Gajera and Krupali Ladani

    Version of Record online : 26 MAY 2010, DOI: 10.1211/jpp.62.05.0008

  16. Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX-2 Versus COX-1 in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 48, Issue 6, June 2008, Pages: 745–754, Dr Jules I. Schwartz, Dr Aimee L. Dallob, Mr Patrick J. Larson, Dr Omar F. Laterza, Ms Jutta Miller, Dr Jane Royalty, Ms Karen M. Snyder, Mr Derek L. Chappell, Ms Deborah A. Hilliard, Ms Mary E. Flynn, Dr Paul F. Cavanaugh Jr and Dr John A. Wagner

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008317590

  17. A liquid chromatography–mass spectrometry method for the quantification of both etoricoxib and valdecoxib in human plasma

    Biomedical Chromatography

    Volume 19, Issue 2, March 2005, Pages: 113–118, Ulrike Werner, Dierk Werner, Burkhard Hinz, Christoph Lambrecht and Kay Brune

    Version of Record online : 7 OCT 2004, DOI: 10.1002/bmc.423

  18. Etoricoxib improves pain, function and quality of life: results of a real-world effectiveness trial

    International Journal of Rheumatic Diseases

    Volume 13, Issue 2, May 2010, Pages: 144–150, Hsiao-Yi LIN, Tien-Tsai CHENG, Jyh-Horng WANG, Chyou-Shen LEE, Ming-Han CHEN, Vanessa LEI, Christina LAC, Arnold R. GAMMAITONI, Steven S. SMUGAR and Wen-Jer CHEN

    Version of Record online : 18 MAR 2010, DOI: 10.1111/j.1756-185X.2010.01468.x

  19. Prophylactic Etoricoxib Is Effective in Preventing “First of Ramadan” Headache: A Placebo-Controlled Double-Blind and Randomized Trial of Prophylactic Etoricoxib for Ritual Fasting Headache

    Headache: The Journal of Head and Face Pain

    Volume 52, Issue 4, April 2012, Pages: 573–581, Michael J. Drescher, Zev Wimpfheimer, Samer Abu Khalef, Arnold Gammaitoni, Naim Shehadeh and Rafael Torgovicky

    Version of Record online : 16 AUG 2011, DOI: 10.1111/j.1526-4610.2011.01993.x

  20. You have free access to this content
    Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: A randomized controlled trial

    Arthritis & Rheumatism

    Volume 50, Issue 2, February 2004, Pages: 598–606, Bernard R. Rubin, Robert Burton, Sandra Navarra, Joseph Antigua, John Londoño, Keith G. Pryhuber, Margaret Lund, Erluo Chen, Daryl K. Najarian, Richard A. Petruschke, Zafer E. Ozturk and Gregory P. Geba

    Version of Record online : 5 FEB 2004, DOI: 10.1002/art.20007